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International travel contributes to the global spread of antimicrobial resistance. Travelers’ diarrhea exacerbates the risk of acquiring multidrug-resistant
organisms and can lead to persistent gastrointestinal disturbance post-travel.
However, little is known about the impact of diarrhea on travelers’ gut
microbiomes, and the dynamics of these changes throughout travel. Here, we
assembled a cohort of 159 international students visiting the Andean city of
Cusco, Peru and applied next-generation sequencing techniques to 718
longitudinally-collected stool samples. We ﬁnd that gut microbiome composition changed signiﬁcantly throughout travel, but taxonomic diversity
remained stable. However, diarrhea disrupted this stability and resulted in an
increased abundance of antimicrobial resistance genes that can remain high
for weeks. We also identiﬁed taxa differentially abundant between diarrheal
and non-diarrheal samples, which were used to develop a classiﬁcation model
that distinguishes between these disease states. Additionally, we sequenced
the genomes of 212 diarrheagenic Escherichia coli isolates and found those
from travelers who experienced diarrhea encoded more antimicrobial resistance genes than those who did not. In this work, we ﬁnd the gut microbiomes
of international travelers’ are resilient to dysbiosis; however, they are also
susceptible to colonization by multidrug-resistant bacteria, a risk that is more
pronounced in travelers with diarrhea.
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The gut microbiota plays a critical role in deterring colonization by
exogenous microorganisms1. International travel to destinations with
high-infectious disease burdens can alter the gut microbiome and lead
to the acquisition of multidrug-resistant organisms (MDRO)2, which

may then spread locally when the traveler returns home3,4. Travelers’
diarrhea affects 10–70% of travelers from low infectious disease-risk
countries visiting middle- and high-risk destinations5–8. Diarrhea can
disrupt travel plans, lead to long-term chronic health consequences
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such as post-infectious irritable bowel syndrome, and can increase risk
for MDRO colonization6,9. As travelers’ diarrhea is predominately
caused by bacterial etiologies6, antimicrobials are routinely used for
treatment and prophylaxis10; however, such use compounds the risk
for MDRO colonization. For example, Arcilla et al. reported 34% of
Dutch travelers acquired extended-spectrum beta-lactamase (ESBL)producing Enterobacteriaceae during travel with carriage lasting up to
12 months post-travel and observed transmission to non-traveling
household members4. Importantly, those who developed diarrhea or
took antibiotics during their stay abroad were more likely to acquire
these ESBL-producing Enterobacteriaceae4.
Previous studies on the impact of international travel on gut
microbiome changes and MDRO acquisition have been largely
limited to the collection of pre- and post-travel stool samples or
have focused on select cultivable antimicrobial-resistant (AMR)
organisms2–4,11–14. Thus, there is limited understanding about how
the taxonomic and functional architecture of the gut microbiome
changes during travel, how these are affected by diarrheal episodes, and how those dynamics inﬂuence MDRO acquisition and
antimicrobial resistance gene (ARG) carriage. For example, following acute perturbation by infectious diarrhea, the gut microbiomes of non-traveling populations return to a healthy prediarrheal state within 1 month15; however, the gut microbiomes of
international travelers are subject to additional chronic perturbations (e.g., different microbial ecology, dietary changes) which
may shift the microbiome over time towards a more local state16.
We hypothesize these chronic perturbations prevent the microbiome of international travelers from returning to a pre-diarrheal
state, and that diarrhea markedly increases the rate of divergence
from baseline. These dynamics can only be assessed with longitudinal studies which sample travelers’ microbiome throughout
the length of stay. In addition, while we know that international
travel results in acquisition of select pathogenic MDROs3, it is less
clear how travel affects the overall carriage of ARGs in the
broader microbiome. We hypothesize that length of stay in middle- and high-risk destinations are directly related to the prevalence of ARGs harbored by the gut microbiota, and—as with
microbiome divergence—diarrhea accelerates this rate of
increase. Analyzing the entire microbiome and resistome enables
a comprehensive evaluation and stratiﬁcation of travel risks, such
as duration in-country, microbiome features, total ARG content,
and occurrence of diarrhea. In this work, we address these
questions by applying whole metagenome and whole genome
sequencing to an extensive collection of longitudinally collected
fecal samples and cultured bacteria from travelers from multiple
countries visiting a common international destination. We show
that the gut microbiomes of international travelers’ are resilient
to dysbiosis; however, they are susceptible to colonization by
multidrug-resistant bacteria, a risk that is more pronounced in
travelers with diarrhea.

Methods) were retrospectively classiﬁed into the “Travelers who
experienced Diarrhea” (TD) group, while the 46 individuals who did
not experience diarrhea were classiﬁed into the “Healthy Travelers”
(HT) group (Fig. 1b). In total, we collected 718 stool samples, comprised of 144 diarrheal and 574 non-diarrheal sample types (HT n = 212,
TD n = 362), with a median of four samples per individual (range: 1–22;
Supplementary Fig. 1a–d). Additionally, we sub-divided TD subjects’
samples into: non-diarrheal samples collected before the subject
experienced diarrhea (PreTD), diarrheal samples (TD), and nondiarrheal samples taken after the subject experienced diarrhea
(PostTD). All HT samples are non-diarrheal. Most individuals in the TD
group experienced their ﬁrst diarrheal episode within 1 month of
arrival (78/113, 69%). Detailed demographic, medical history, and
dietary data were collected from each participant (see Methods), and
cohort characteristics with a summary of metadata features are listed
in Supplementary Table 1. We observed no signiﬁcant differences
between HT and TD subjects with respect to age, sex, trip duration, or
other demographic factors in univariable logistic regression analyses
(Supplementary Tables 1 and 2; Supplementary Fig. 1b, c).
To characterize the gut microbial communities of travelers, we
performed whole metagenome shotgun sequencing on the 718 stool
samples and generated taxonomic composition (using MetaPhlAn217),
and antibiotic resistome (using ShortBRED18) proﬁles (Fig. 1b, Supplementary Fig. 2a, b). These proﬁles were supplemented with multiplex
PCR on 696 stool samples and cultures to identify common diarrheagenic pathogens; whole genome sequencing of 212 diarrheagenic
Escherichia coli (DEC) isolates to evaluate phylogenetic diversity and
ARG content (Fig. 1c, Supplementary Fig. 2c, d); antibiotic susceptibility testing on 169 DEC isolates to determine phenotypic resistance
(Fig. 1d, Supplementary Fig. 2e); and the construction of 21 functional
metagenomic libraries19–23 from 210 stool samples to characterize the
antibiotic resistome in a sequence- and culture-unbiased manner
(Supplementary Fig. 2f).
Among all the metadata variables, inter-individual variation
accounted for the largest variation (44–52%) in taxonomic and resistome proﬁles (Supplementary Table 3, see Methods). For the other
metadata variables, we observed relatively small (up to 4%) but signiﬁcant variation associated with stool grade, sample type, country of
residence, and duration of stay after correcting for multiplehypothesis testing (all FDR P < 0.05; full results in Supplementary
Table 3). Pathogen presence (identiﬁed by multiplex PCR) and subject
age were also signiﬁcantly associated with taxonomic but not with
resistome proﬁles, while sample collection time was signiﬁcantly
associated with resistome but not with taxonomic proﬁles (Fig. 1e,
Supplementary Table 3). Therefore, we conclude that these signiﬁcant
features (stool grade, sample type, country of residence, duration of
stay, pathogen presence, age, and sample collection time) have systematic effects on the microbial community.

Results

Our longitudinally-collected metagenomic samples enabled us to
evaluate the short- and long-term changes to travelers’ gut microbiomes. Overall, the taxonomic diversity of the travelers’ gut microbiota was temporally stable throughout the duration of their stay. As
determined by linear mixed effect models (LMM; subject as random
effect), the Shannon diversity of all HT and TD subjects’ sample types
were stable over time and did not signiﬁcantly differ from each other
(Fig. 2a, LMM, P > 0.05, Supplementary Table 4a); however, the richness of PostTD non-diarrheal samples was signiﬁcantly lower compared to HT samples over time (LMM, P < 0.001, Supplementary
Table 4a). In addition, when we compared TD individuals’ diarrheal
samples (TD) with matched non-diarrheal samples collected within
2 weeks before (PreTD) and after diarrhea (PostTD), we observed a
signiﬁcant decrease in both richness (GLMM, P < 0.001) and Shannon

Overview of international travelers cohort
We assembled a prospective cohort of 159 international students (60%
female, 40% male; median age: 24 years; age range: 18–65 years)
attending the Amauta Spanish language school in the city of Cusco,
Peru between June 2012 and July 2016. Participants originated from 16
low infectious disease-risk countries, and their median duration of
participation was 35 days (interquartile range (IQR): 33 days; range:
2–173 days) (Fig. 1a). Stool samples were collected upon enrollment
within 48 h of their arrival to Cusco and weekly thereafter, with additional samples collected during diarrheal events. The 113 individuals
who experienced at least one episode of diarrhea during their stay
(deﬁned as one or more semi-liquid or watery bowel movements
associated with the presence of gastrointestinal symptoms, see
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diversity (Fig. 2b, LMM, P < 0.05) following diarrhea (Supplementary
Table 4b).
While taxonomic diversity remained relatively constant, all participants’ gut microbial communities underwent signiﬁcant restructuring throughout the course of their travel abroad. First, we compared
the beta-diversity of participants’ consecutive stool samples. We found
a

that individuals in the TD group had greater apparent variation and
less stable microbial architecture throughout the length of their stay
than those in the HT group (Fig. 2c, LMM P < 0.001, Supplementary
Table 5a). Importantly, we observed that individuals with greater
taxonomic diversity at baseline were signiﬁcantly more resilient to
change than individuals with lower baseline diversity (LMM, P (baseline
b
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Fig. 1 | Study design, data assembly, and meta-analysis for cohort of international travelers. a Highlighted regions of the map show countries of residence for
travelers in our cohort who visited the Andean city of Cusco, Peru between June
2012 and July 2016. Most traveled from North America or the European subcontinent. The Circos plot at the bottom shows the distribution of samples collected per individual, color-coded by their country of residence. b Sampling
strategy and experimental design: Subjects who did not experience diarrhea during
course of stay were classiﬁed as Healthy Travelers (HT, blue), while those who
experienced at least one episode of diarrhea were classiﬁed as Travelers with
Diarrhea (TD, orange). Collected stool samples were processed to obtain taxonomic, and resistome proﬁles using metagenomics sequencing. A subset of samples were cultured to obtain suspected diarrheagenic pathogens, tested for
antibiotic susceptibility, and sequenced for detailed comparative genomic analysis.

Additionally, functional metagenomics libraries were prepared and screened
against 17 antibiotics to characterize resistomes in the stool samples. c Upset plot
depicting the frequency of diarrheagenic pathogens that were detected using
multiplex PCR in non-diarrhea (green) and diarrhea samples (red). d Antibiotic
susceptibility testing of diarrheagenic E. coli isolates against 20 antibiotics. Percentage and coloring of heatmap shows the proportion of isolates in a DEC
pathotype resistant to the given antibiotic, with colored bar indicating antibiotic
class. d PERMANOVA test quantifying the total variance explained by metadata
variables in the taxonomic (MetaPhlAn217) and resistome (ShortBRED18) proﬁles.
The y axis indicates the total variance explained and the x axis represents different
metadata variables that were tested (*P < 0.05; **P < 0.01; ***P < 0.001). Underlying
data are provided in the Source Data ﬁle.

Shannon index) <0.001; Supplementary Table 5a). This is in-line with
previous reports indicating that microbial diversity is an important
contributor to overall intra-subject microbial stability and colonization
resistance to enteric pathogens, with a lower pre-travel diversity being
signiﬁcantly associated with increased susceptibility to infection24.
Next, to quantify divergence from the baseline gut microbial composition we compared the beta-diversity, measured by Bray–Curtis dissimilarity and the Jaccard index, of each travelers’ samples to their ﬁrstweek baseline sample. We found that the taxonomic composition of
participants in both the HT and TD groups changed signiﬁcantly over
the length of stay (Fig. 2d, LMM, P(Time_diff_days) <0.001, Supplementary Table 5b), likely as a consequence of travelers’ exposure to the
different environmental microbial milieu of Peru compared to their
home country. Notably, principal coordinate analysis (PCoA) of
Bray–Curtis dissimilarity between TD samples which were temporally
matched with before, during, and after diarrhea showed marked heterogeneity, suggesting that inter-individual variability among the
samples exceeds the effect of diarrhea-induced changes (Supplementary Fig. 3a). Nevertheless, we observed a weak association
between samples based on whether they were collected before, during, or after diarrhea (Supplementary Fig. 3a, PERMANOVA,
P = 0.009, R2 = 0.10).
To evaluate large-scale perturbations in HT and TD subjects’ gut
microbiota, we searched for “microbiome shift” events. These are
deﬁned as when the Bray–Curtis dissimilarity between an individual’s
consecutive samples (within a week) is greater than the dissimilarity
between individuals (Supplementary Fig. 3b, see Methods)25. Using this
approach, we identiﬁed 141 shift events (34.5%, 141/408). TD individuals had a signiﬁcantly higher proportion of shift events than HT
subjects (TD: 40.4%, 113/280; HT: 21.9%, 28/128; Fisher exact, P < 0.001;
Supplementary Table 6), and the majority of TD individuals’ shift
events occurred during a diarrheal episode (67.3%, 76/113; Supplementary Table 6). These ﬁndings suggest that HT and TD subjects have
similar gut microbial stability patterns, but large-scale disruptions
occur most frequently during diarrhea.
While prior studies on infectious diarrhea among non-traveling
native populations suggest an orderly reversal to the pre-diarrhea state
within 1 month of the diarrheal episode15, our cohort’s microbial
compositions increasingly diverge from baseline over the course of
individuals’ stays (Fig. 2d, LMM P < 0.001), and did not return to
baseline at least for the duration of their stay. Thus, we sought to
determine how experiencing diarrhea affects divergence from baseline, and whether rates of divergence might be a predictor of who will
get diarrhea. We compared the Bray–Curtis dissimilarities of HT and
TD subjects’ 1st week baseline sample with a non-diarrheal sample
collected 1 month later. We further subdivided the TD group between
those who experienced diarrhea before 1 month (Early TD) or after
1 month (Late TD). Early TD subjects had signiﬁcantly higher dissimilarity after 1 month of travel than the other groups (Fig. 2e, Wilcoxon
signed-rank test, P < 0.01). This suggests that while all subjects’
microbiomes continuously diverge from baseline during travel,

diarrhea is an impactful perturbation that signiﬁcantly increases this
divergence. Further, we observed no signiﬁcant difference between HT
and Late TD subjects (Fig. 2e, Wilcoxon signed-rank test P > 0.05). This
suggests that the divergence of Late TD subjects prior to diarrhea is
indistinguishable from those who will not get diarrhea (HT), thereby
precluding the use of diversity metrics alone as an early predictor of
who will get diarrhea. This motivated us to quantify the taxonomic
differences between subject groups at higher resolutions.
We found that diarrhea signiﬁcantly altered the composition of
major gut microbial phyla (Supplementary Fig. 3c). Diarrheal samples
were characterized by enrichment for Proteobacteria and Bacteroidetes, and a depletion of Firmicutes, resulting in a lower Firmicutesto-Bacteroidetes ratio (Supplementary Fig. 3d, Wilcoxon signed-rank
test, P < 0.001). This is consistent with other gastrointestinal diseases
and is associated with a dysbiotic gut microbial architecture26. However, we observed no signiﬁcant difference in the Firmicutes-toBacteroidetes ratio between the before (PreTD) and after diarrhea
(PostTD) samples (Supplementary Fig. 3d, Wilcoxon signed-rank test,
P > 0.05), suggesting that, while the overall composition does not
return to the pre-diarrheal state, these speciﬁc phyla quickly recover.
At species-level resolution, we identiﬁed 39 differentially abundant
species associated with diarrheal and non-diarrheal samples using
multivariable regression models (using MaAsLin227) (Fig. 2f–g, Supplementary Fig. 4). In diarrheal samples, we found an elevated relative
abundance of bacteria with known diarrhea-causing pathogenic strains
(e.g., E. coli, and Shigella spp.). Additionally, we saw an increased
abundance of Proteobacteria (e.g., Bilophila spp., Sutterella wadsworthensis, Parasutterella excrementihominis, and members of the
Burkholderiales order (Fig. 2f–g). Previous studies have linked these
taxa to host physiology and health outcomes28–32, such as an increased
abundance of Bilophila spp. being associated with inﬂammatory bowel
disease29, and increased abundance of Sutterella wadsworthensis being
associated with ulcerative colitis etiology and fecal microbiota transfer
treatment failure30–32. We also observed a signiﬁcant increase in the
relative abundance of several taxa within the Bacteroidetes phylum
(e.g., Odoribacter splanchnicus, Bacteroides fragilis, Bacteroides vulgatus), consistent with previous reports on diarrheal diseases33,34. Bacteroides are major producers of sphingolipids that regulate
inﬂammation and immunity in the human gut35, and a bloom during
diarrhea may reﬂect an effort to restore microbial homeostasis36,37. In
contrast, several taxa belonging to the Firmicutes phylum were
depleted in diarrheal samples (e.g., Ruminococcus bromii, Eubacterium
rectale, Clostridium bartlettii, Coprococcus spp.). Many Firmicutes are
residents of healthy guts and are known to play key functions,
including maintenance of gut barrier function and digestion of complex polysaccharides by producing short-chain fatty acids38. A
decreased representation of Firmicutes has also been associated with
other gastrointestinal diseases, including ulcerative colitis and Crohn’s
disease39.
In concordance with prior studies40–42, no identiﬁable etiologic
agent was detected in ~50% of the diarrheal samples in our study, even

Nature Communications | (2022)13:7485

4

Article
e

b

P[Time in Peru] = 7.73e−01
P[diarrhea TD] = 1.85e−01
P[Non-diarrhea Pre TD] = 4.50e−01
P[Non-diarrhea Post TD] = 1.41e−01

0.8

0.18

3

2

0.035

0.23

0.008

3

2

1

1
10

20

30

40

50

60

70

80

90

100

Non−diarrhea
(PreTD)

Time in Peru (days)
Non-diarrhea (HT)
Non-diarrhea (PreTD)

0.6

0.4

0.2

0

0

ns

0.034

4

Bray-Curtis dissimilarity index

Shannon Index (Microbial species)

4

Shannon index (Microbial species)

a

https://doi.org/10.1038/s41467-022-34862-w

Diarrhea
(TD)

TD 1st week
HT 1st week
vs
vs
Early TD
Late HT
(after 1 month) (diarrhea within
1 month)

Non−diarrhea
(PostTD)

Non-diarrhea (PostTD)
Diarrhea (TD)

TD 1st week
vs
Late TD
(No diarrhea
within1month)

Non-diarrhea sample
Diarrhea sample

c

d
1.00

Depleted in diarrhea
Rothia_mucilaginosa

0.50

Odoribacter_splanchnicus
Bacteroides_caccae
Bacteroides_vulgatus
0.25

Alistipes_finegoldii
Alistipes_putredinis
Bacteroides_fragilis
Bacteroides_nordii

0.00

0.00
0

10

20

30

40

50

60

70

80

90

100

Time in Peru (days)

Bacteroides_salyersiae
0

10

20

30

40

50

60

70

80

90

100

Time difference from 1st week baseline sample (days)
Healthy Travelers

Barnesiella_intestinihominis
Coprobacter_fastidiosus
Alistipes_shahii

Travelers with diarrhea

Bacteroides_finegoldii
Bacteroides_thetaiotaomicron
Parabacteroides_distasonis
Parabacteroides_unclassified

g

Sutterella wadsworthensis

Escherichia coli

FDR 2.44e−07

Bacteroides_cellulosilyticus
FDR 3.65e−06

Bacteroides_massiliensis
Bacteroides_uniformis

Density

Parabacteroides_merdae
Dorea_formicigenerans
Streptococcus_mitis_oralis_pneumoniae
Streptococcus_infantis
Veillonella_atypica
−2.5

0.0

2.5

−2.5

0.0

2.5

Bilophila_unclassified

Ruminococcus bromii

Dorea formicigenerans
FDR 4.38e−11

Sutterella_wadsworthensis

FDR 1.59e−03

Escherichia_coli
Bilophila_wadsworthia

Density

Burkholderiales_bacterium_1_1_47
Parasutterella_excrementihominis
Shigella_sonnei
Coprococcus_sp_ART55_1
Clostridium_bartlettii
−2.5

0.0

2.5

Bacteroides caccae

−2.5

0.0

2.5

FDR 5.38e−05

Clostridium_leptum
Leuconostoc_mesenteroides

Odoribacter splanchnicus

Enterococcus_durans

FDR 4e−10

Lactococcus_lactis

Density

Peptostreptococcaceae_noname_unclassified
Ruminococcus_bromii

−2.5

0.0

2.5

log10 (abundance relative to HT median)

−2.5

0.0

2.5

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
−
−
−
−
−
−
−
−

log10 (abundance relative to HT median)

Marginal fixed effect estimate
(Sample code = D)
Log nomalized FDR value
−6

Non-diarrhea (PreTD)

Diarrhea (TD)

Non-diarrhea (PostTD)

0

24

Non-diarrhea (HT)
Firmicutes

Fig. 2 | Travelers’ gut microbiome compositions change throughout travel,
with diarrhea-causing large-scale disruptions. a Taxonomic diversity (Shannon
index) of subjects’ microbiomes throughout their length of stay, as days postarrival. Points are individual samples, colored by sample type with dotted lines
connecting samples from the same subject. Solid lines show the best ﬁt line for
different sample types: HT (blue), diarrheal (red), non-diarrheal preTD (green), and
postTD samples (yellow) (n = 617, LMM, all P > 0.05), and the gray shading represents 95% conﬁdence interval (CI). b Boxplots of the taxonomic diversity of subjectmatched diarrheal and non-diarrheal samples collected within 2 weeks (n = 171,
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<1 month of arrival) and Late TD (who experienced diarrhea >1 month after arrival)
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associated with diarrhea samples detected using MaAsLin227 where subjects were
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Fig. 3 | Development of machine learning classiﬁer that uses species abundances to distinguish between diarrheal and non-diarrheal sample types. a The
heatmap showing the relative abundances of top 20 discriminatory taxa between
diarrheal and non-diarrheal PreTD types. Barplot depicts the effect size of the
discriminatory taxa obtained from Random forest model. Cross-validation accuracy depicted as AUC-ROC and Precision-recall curve for the models built with
three independent methods: ElasticNet (blue), Lasso (red) and Random Forest
(green). b Co-occurrence network of diarrheal (left) and non-diarrheal (right)
samples. The sizes of the nodes are proportional to the mean relative abundances
of the species. The edges between two nodes represent signiﬁcant correlations
(green: positive; red: negative) between the two species. The orange highlighted

region shows Bacteroidetes that are enriched in diarrhea (left) compared to nondiarrhea (right) network. The blue-highlighted region shows a conserved relationship among Firmicutes in both networks. c Circos plot depicting the common subnetwork species between diarrheal and healthy sample networks. Node sizes are
proportional to their scaled NESH score obtained from Netshift45, and species that
gained connectivity in the diarrhea network compared to the healthy network are
colored red. Connectivity changes between the common subnetworks are represented by connections between these species (red: connections that are unique to
diarrhea samples network; blue: connections that are shared in both networks;
green: connections that are unique to non-diarrheal samples network). Underlying
data are provided in the Source Data ﬁle.

when using multiplex PCR. Although we observed signiﬁcant alterations for a number of species between the diarrheal and non-diarrheal
samples (Fig. 2f), these changes could be either a signature of dysbiotic
gut or disease-speciﬁc alteration. The disease-speciﬁc microbiome
changes may reﬂect potential pathogens or pathobionts exploiting
diarrhea-induced changes in the intestinal milieu. Thus, to discern
diarrhea-speciﬁc microbial signatures, we subsampled the diarrheal
samples (TD) and non-diarrheal samples collected before diarrhea
episode (PreTD) and employed machine learning methods on the
abundances of key taxa. Speciﬁcally, we applied three approaches viz.
ElasticNet, Lasso, and Random Forest (RF) using SIAMCAT43. Among
these, the RF model had the best accuracy (84.9%) and precision-recall
(89.7%) (Fig. 3a). Consistent with prior observations, 8 of these 20 top
discriminatory species belonged to the Bacteroides family. The top
ﬁve species with the largest effect sizes were C. bartlettii, E. coli, Peptostreptococcaceae unclassiﬁed, L. lactis, and B. thetaiotamicron. Apart

from E. coli, the other four species are key commensal species that
were depleted during diarrhea.
Lastly, to understand how these individual taxa interact with each
other during diarrhea, we built two unsupervised co-occurrence networks from diarrheal and non-diarrheal samples (using SparCC44)
(Fig. 3b) and then compared these correlation networks using
Netshift45 (Fig. 3c) to identify “driver” taxa responsible for differences.
This identiﬁed 14 taxa that showed signiﬁcant shifts in their interactions in diarrhea compared to non-diarrheal samples (Fig. 3c, highlighted in red). Among them, E. coli and Escherichia spp. Unclassiﬁed
were enriched during diarrhea, gained connectivity, and were negatively associated with key commensal species such as Eubacterium
rectale. Bacteroidetes species such as B. uniformis and B. caccae were
also enriched, gained interactions, and formed a close sub-network of
positive interactions with other Bacteroides species (Fig. 3b, highlighted in orange). During diarrhea, other commensal microbes
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including F. prausnitzii and Ruminococcus bromii were depleted and
lost their connectivity to other microbial species (Supplementary
Table 7). While the gut microbiome underwent major remodeling
during diarrhea, a sub-network built from D. longicatena, D. formicigenerans, E. hallii, R. obeum, and R. sp_5_1_39BFAA remained conserved with no change in interactions between each other (Fig. 3b,
highlighted in blue). Notably, many of these interconnected and differentially interacting taxa were also found to be differentially abundant by the LME (MaAsLin227) (Fig. 2f), as well discriminatory between
PreTD and TD sample types by the RF model (SIAMCAT43) (Fig. 3a).

Temporal dynamics of antibiotic resistance gene diversity and
abundance
Having characterized the dynamics of changes to the gut microbiome
during travel, we next sought to determine if similar trends characterize the travelers’ gut antibiotic resistomes. To capture both
known and potentially sequence-novel functional ARGs encoded by
international travelers’ gut microbiota in a high-throughput, sequenceand culture-unbiased manner, we constructed 21 functional metagenomic libraries (representing 89.5 GB) from 210 stool samples randomly selected from the full set of 718 samples (see Methods). These
libraries were screened against 17 antibiotics (Supplementary Data 1),
with resistance found against all antibiotics screened except for
ciproﬂoxacin and meropenem (Supplementary Fig. 2f). Resistance was
most abundant for trimethoprim and tetracyclines, and lowest for
colistin and 3rd/4th generation cephalosporins. The metagenomic
inserts from these resistant transformants were sequenced, assembled, and annotated for AR function using our previously published
pipeline18,19 (see Methods). This yielded 2,065 unique ARG sequences,
expanding the catalog of known ARGs harbored by the gut microbiota.
We then built an extensive ShortBRED18 AR protein sequence marker
database by incorporating ARG sequences from this cohort (n = 2065),
12 other published functional metagenomic studies (Supplementary
Table 8), and two curated ARG databases (CARD46 v2.2.0; NCBI-AMR47
v1.0), resulting in a database consisting of 6,594 unique marker
sequences representing 2,314 ARG families (Supplementary Data 2).
The relative abundance of ARGs in the sequenced metagenome of each
stool sample was then quantiﬁed by mapping the shotgun data to the
ShortBRED marker database.
The diversity of gut resistomes harbored by travelers’ gut microbiota demonstrated temporal stability for the duration of travel.
Similar to microbiome diversity, Shannon diversity of ARGs from HT
and TD subjects’ samples showed no signiﬁcant change over the length
of travel (Fig. 4a; LMM, P > 0.05, Supplementary Table 9a). However,
diarrheal samples ARG richness signiﬁcantly increased over time
compared to HT samples (LMM, P < 0.01; Supplementary Table 9a),
suggesting subjects who experienced diarrhea later had a greater
diversity of ARGs. We also did not observe a signiﬁcant change in
cumulative ARG abundance (RPKM) over length of travel (Fig. 4b,
LMM, P > 0.05, Supplementary Table 9a). We observed a marked
increase in ARG richness (LMM, P < 0.001) and abundance (LMM,
P < 0.001) among individuals who reported using antibiotics in the
preceding week (Supplementary Table 9b). When comparing the betadiversity of individuals’ gut resistomes from consecutive samples (by
Jaccard and Bray–Curtis index), we observed TD subjects’ samples
were signiﬁcantly more dissimilar than HT, indicating the TD resistome
is less stable (Supplementary Fig. 5a, LMM, P < 0.05; Supplementary
Table 10a). We also observed signiﬁcantly increased similarity by Jaccard index in later samples, suggesting greater resistome restructuring
occurs earlier in travel (LMM P < 0.05; Supplementary Table 10a).
Further, when comparing subjects’ samples to their 1st week baseline
sample, we observed signiﬁcantly increased dissimilarity with
increasing time differences between the samples compared, indicating
restructuring occurs throughout the length of travel (Supplementary
Fig. 5b, LMM, P < 0.05; Supplementary Table 10b).
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However, diarrhea transiently increases ARG diversity and abundance. Comparison of diarrheal samples with matched non-diarrheal
samples collected within 2 weeks (PreTD) showed diarrheal samples
had signiﬁcantly increased ARG richness (GLMM, P (DiarrheaTD)
<0.001), Shannon diversity (Fig. 4c, LMM, P (DiarrheaTD) <0.001), and
cumulative ARG abundance (Fig. 4d, LMM, P (DiarrheaTD) <0.001,
Supplementary Table 9c). While ARG richness and diversity recovered
to PreTD levels within 2 weeks after diarrhea (PostTD), ARG abundance
remained signiﬁcantly high (Fig. 4d; LMM, P < 0.001, Supplementary
Table 9c). Further, we ﬁnd this increase in abundance of ARGs during
diarrhea was signiﬁcantly correlated with a decrease in microbial
diversity at the species-level (Fig. 4e, LMM, P < 0.001) but an increase in
relative abundance of Enterobacteriaceae (Fig. 4e, LMM, P < 0.01). This
suggests that the majority of AMR determinants in diarrheal samples are
likely concentrated within Enterobacteriaceae species. Additionally, we
observed a signiﬁcant negative correlation of ARG abundance with
species belonging to Ruminococcaceae (LMM, P < 0.001), Eubacteriaceae (LMM, P < 0.001), Coriobacteriaceae (LMM, P < 0.01), and Biﬁdobacteriaceae (LMM, P < 0.01) (Supplementary Fig. 5c). Finally, we
sought to identify speciﬁc ARGs that were differentially abundant in
diarrheal samples using MaAsLin227. Diarrheal samples had an increased
abundance of antibiotic efﬂux pumps, β-lactamases (Class A and Class
C), and aminoglycoside resistance genes, while non-diarrheal samples
were enriched for tetracycline ribosomal protection genes (Fig. 4f–g,
Supplementary Fig. 5d, Supplementary Fig. 6). Importantly, many of
these ARG families that are enriched in diarrhea samples are commonly
encoded in Enterobacteriaceae species.

Phenotypic and phylogenetic analyses of diarrheagenic
pathogens
As bacterial etiologies are the predominant cause of travelers’
diarrhea48, we evaluated both diarrheal and non-diarrheal stool samples for the presence of common diarrheagenic pathogens. We performed multiplex PCR on 696 stool samples and cultures to detect
Campylobacter spp., Shigella spp., norovirus (GI, GII), and six strains of
diarrheagenic E. coli (DEC) (Supplementary Table 11; Supplementary
Information). At least one diarrheagenic pathogen was detected in 217/
696 samples (31.2% overall; 62/142, 43.7% diarrheal; 155/554, 28.0%
non-diarrheal). No pathogen was detected in 80/144 (55.6%) diarrheal
samples, consistent with the previous reports7. DEC were the most
common group of pathogens detected (193/217, 88.9%), followed by
Norovirus (29/217, 13.4%), Campylobacter spp. (18/217, 8.3%), and Shigella spp. (3/217, 1.4%) (Fig. 1c; Supplementary Table 11; Supplementary
Information). Simultaneous detection of ≥2 enteropathogens was
observed (24/217, 11.1%), predominantly for different DEC strain types
(19/217, 8.8%). To analyze DECs directly, we cultured 212 DEC isolates
from 195 fecal samples (157 isolates from 149 non-diarrheal samples,
and 55 isolates from 46 diarrheal samples). To assess AMR phenotypes,
we performed antimicrobial susceptibility testing on 169 DEC isolates
against 20 antibiotics belonging to 12 antimicrobial classes (Supplementary Table 12). The majority of DEC isolates (66.9%, n = 113) were
multidrug-resistant (MDR; deﬁned as resistance to ≥1 antimicrobial
agent in ≥3 antimicrobial classes; Supplementary Fig. 2e). We observed
moderate rates of resistance to azithromycin (AZM; 23.7%, n = 40) and
ciproﬂoxacin (CIP; 7.7%, n = 20), two antibiotics recommended for the
treatment of acute diarrhea48 (Supplementary Fig. 2e).
Next, we sequenced the genomes of all 212 DEC isolates to
investigate the genomic diversity, ARG content, and virulence potential of these enteropathogens. The draft assemblies were quality ﬁltered and 23 isolates with poor assembly metrics were excluded
(Supplementary Fig. 2c, d, see Methods). We analyzed the population
structure of the quality ﬁltered genomes, along with 40 publicly
available E. coli genomes of diverse pathotypes, by constructing a coregenome (2216 genes, ≥95% identity) maximum-likelihood phylogenetic tree (using Roary49 and RAxML50) (Fig. 5). The phylogenetic
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clusters were independently conﬁrmed using BAPS51. Our DEC isolates
grouped into 6 distinct clusters corresponding to phylogroups A, B1,
B2, D, E, and F. The majority belonged to Clade A (106/189; 56.1%) and
Clade B1 (56/189; 29.6%). No signiﬁcant association between phylogroups and sample type (diarrheal vs. non-diarrheal) was observed
(Fishers exact test, P > 0.05), except for isolates belonging to Clade B2
and Clade F that were isolated only from non-diarrheal samples.
DEC strains isolated from non-diarrheal samples in TD subjects
encoded more ARGs than isolates from HT subjects (Fig. 6a; Supplementary Fig. 7a, b) (non-diarrheal HT vs. non-diarrheal TD, Wilcox test,
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P < 0.05). These isolates were signiﬁcantly enriched for blaTEM-148, sul2,
aph6, and tetA genes (Fig. 6a). Notably, several DEC strains isolated
from TD subjects also carried other clinically signiﬁcant AMR genes
including, ESBL genes (blaCTX-M, n = 7; blaOXA, n = 3), AmpC (blaCMY,
n = 1), and mcr-1 (n = 1). Notably, mcr-1 was ﬁrst described in the literature in 201652,53, whereas this mcr-1 harboring isolate was cultured in
2013. Colonization with multidrug-resistant DEC strains could have
long-term consequences both during and after travel, such as infection
by the pathobiont or horizontal transfer of its MDR genes to another
pathogen leading to treatment failure or other adverse clinical
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Fig. 4 | Diarrhea increases ARG diversity and abundance. a The alpha diversity
(Shannon index) of subjects’ resistomes throughout the length of their time in Peru,
as days post-arrival. Points are individual fecal samples, colored by sample type (i.e.,
diarrhea or non-diarrhea), with dotted lines connecting samples from the same
subject. Solid lines show the best ﬁt for different traveler types: HT (blue), diarrheal
(red), non-diarrheal pre-TD (green), and post-TD samples (yellow) (n = 617, LMM,
P > 0.05) and the gray shading represents 95% conﬁdence interval (CI).
b Cumulative abundance of ARGs (log10 scale) over time. Points are individual
samples with dotted lines connecting samples from the same subject. Solid lines
show best ﬁt with 95% CI (gray shading) of samples from different traveler types
(n = 617, LMM, P > 0.05). c Boxplots of ARG diversity (Shannon index) of subjectmatched diarrheal samples with non-diarrheal samples collected within 2 weeks of
diarrhea. Accompanying violin plots show the distribution (n = 171 samples, twosided Wilcoxon test). d Cumulative abundance of ARGs of subject-matched diarrheal samples with non-diarrheal samples collected within 2 weeks of diarrhea.

Accompanying violin plots show the distribution (n = 171 samples; two-sided Wilcoxon test). e Correlations between cumulative abundance of ARGs (log10 scale)
and microbial species diversity (top) and relative abundance of Enterobacteriaceae
(log10 scale) (LMM; all P < 0.001). f ARGs that enriched or depleted in diarrheal
samples compared to non-diarrheal samples. The signiﬁcant associations were
detected by MaAsLin227 where other metadata variables (age, sex, sample type,
region, length of stay, and antibiotics usage) were used as ﬁxed effects in the LMM.
g Relative abundance distribution of differentially abundant ARGs in different
sample types normalized by the median relative abundance of non-diarrheal HT
samples (LMM; all P < 0.001). Left barplot, fraction of samples below detection
limit. Boxes in the boxplots show median and quartiles; error bars extend to the
values within 1.5 interquartile range. P values are multiple-hypothesis test corrected
using Benjamini–Hochberg (FDR) method. Underlying data are provided in the
Source Data ﬁle.

outcomes, and spread to new hosts during and after travel (e.g.,
household members, healthcare facilities)3,4.
We also observed several ARG clusters associated with plasmids.
Pairwise co-occurrence comparisons of accessory AR determinants in
the same contig (within 5 kb) revealed highly interconnected groups of
ARGs among DEC isolates (Fig. 6b). The most common cluster of ARGs
frequently detected together (blaTEM-148, sul2, aph6, aph3, emrE, and
tetA) was also found to be signiﬁcantly associated with plasmids (49%;
25/51; Fisher’s exact test; FDR P < 0.05). Several other ARGs were also
found in plasmid sequences but could not be evaluated because of
their overall low frequency in the dataset (Supplementary Table 13).
We next analyzed the genomic context of these ARGs to assess
transmission risk. We identiﬁed mobile genetic elements (MGE) within
5 kb of the ARGs using MGEﬁnder54 (Fig. 6c, Supplementary Fig. 8),
suggesting these ARGs are able to transfer horizontally. We then built a
co-occurrence network of the observed ARGs with MGEs and identiﬁed
clusters that were more frequently observed together in the isolates.
We identiﬁed four major clusters that include ARGs conferring resistance via different mechanisms (Fig. 6b). The genes sul2, aph6, aph3,
and blaTEM-148 were the most common group observed, occurring in 60
isolates (39.1%). These genes were often observed with the IS26
insertion element (n = 12) and Tn2 unit transposon (n = 12), as well as
with dfrA8/dfrA14 genes (n = 20) and other mobile elements like IS903.
Co-occurrence and co-transfer of these ARGs raise concerns over their
potential expansion and dissemination.
We identiﬁed instances of temporary (1 timepoint) and persistent
(≥2 timepoints) colonization by DEC isolates, as well as co-colonization
of multiple DEC strain types in a single timepoint. For individuals with
≥2 DEC isolates collected from their longitudinal stool samples, we
compared the phylogenetic relatedness of those isolates using
StrainSifter55 (Supplementary Fig. 9). The single-nucleotide variation
(SNV) per megabase of isolates from the same individual was highly
variable, ranging from 0 to 16,833 SNVs. For example, DEC isolates
from HT-P041 on days 33, 39, and 45 had zero SNVs, suggesting a single
strain of E. coli had persisted in that individual’s gut throughout the
two-week period (Supplementary Fig. 9; font colored yellow). In contrast, isolates cultured from the diarrheal sample of TD-P004 collected
on day 77 differed by 9,187 SNVs per megabase, suggesting simultaneous colonization by distinct DEC strain types (Supplementary Fig. 8;
font colored purple). Supporting the case for transient co-colonization, these isolates also showed distinct ARG and VF proﬁles. Coexistence of multiple DEC strains with distinct resistome proﬁles in a
diarrheal sample can potentially affect the ability to treat diarrhea with
antibiotics. Lastly, we calculated the pairwise SNV count from isolates
collected longitudinally from the same subjects, and observed isolates
from HT subjects had greater stability than those from TD subjects,
measured as fewer SNVs (HT median pairwise SNV count = 5218; TD
median SNV count = 8922; t test P < 0.05). We speculate that, as with
the gut microbiome, TD subjects’ E. coli are similarly stable to HT

subjects except during diarrheal episodes when large-scale disruptions
occur (as measured by shift events; Supplementary Table 6) and
commensal E. coli are replaced by DEC. However, in this study, we do
not have the high-resolution sampling around diarrheal episodes
necessary to test this. We also note that these measurements of strain
diversity, as well as counts of temporary and persistent colonization
are likely an underestimate, as higher-resolution studies with greater
sampling frequency have shown that transient colonization of international travelers can last just one or a few days56, and strains could
have persisted under the detection threshold of our culture methods.
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Discussion
Here we report a large longitudinal interrogation of host microbiotapathogen interactions and acquisition of MDRO during international
travel to a region with a high-infectious burden. We observed travelers’ gut microbiome compositions diverging signiﬁcantly from
their baseline microbial architecture throughout the length of their
stay, with the greatest change occurring during the ﬁrst month of
stay. This is likely explained by sustained exposure to a non-native
environment with different microbial ecologies, as well as changes
in diet, surrounding climate, and other environmental factors (e.g.,
altitude)8,57–59. Presumably, travelers’ microbiomes were shifting
towards a more local state wherein this divergence would stabilize;
however, we cannot deﬁnitively claim this as our cohort does not
include samples from the local population, nor was their stay as long
enough as observed in other traveling populations which took
6–9 months to acclimate16. The microbiome diversity of HT subjects
showed remarkable temporal stability, while those of TD subjects
were less stable and had greater variation. The overall temporal
stability of travelers’ gut microbiomes was attributed to higher
baseline microbial diversity. During diarrheal episodes we observed
a dysbiotic microbial architecture marked by the enrichment of
Bacteroidetes and Proteobacteria and contrasting depletion of Firmicutes, similar to the previous reports26. Unlike studies in native
populations15, the microbiomes of our travelers did not return to a
pre-diarrheal state even after 1 month of the diarrheal episode,
which is likely attributed to the microbiome’s continual divergence
due to the non-native environment. We also identiﬁed several taxa
that were differentially abundant between non-diarrheal and diarrheal samples, which were then used to develop a classiﬁcation
model that can distinguish diarrheal from non-diarrheal disease
states with high accuracy and precision-recall. This underscores the
ability of microbiome-based biomarkers to differentiate between
disease and healthy states; however, more studies using traveler
cohorts visiting different geographical locations are needed to
determine the generalizability of these features, and more
mechanistic studies with model systems (e.g., microbiotahumanized gnotobiotic animals60–62) would be needed to elucidate
the putative causal role of these species.
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Fig. 5 | Diarrheagenic E. coli isolates are phylogenetically diverse and encode
many ARGs and VFs. Phylogenetic tree inferred from core-genome alignment of
189 E. coli isolates (this study) and 40 published E. coli reference genomes (marked
by *). Phylogroups are depicted as colored branches of the tree. Annotations, from

inner to outer ring, denote: Gray barplots denote ARG count; E. coli pathotype
(assigned by the presence/absence of speciﬁc VFs; Methods); VF count; and sample
type (diarrheal or non-diarrheal). Underlying data are provided in the Source
Data ﬁle.

By complementing metagenomic sequencing with functional
metagenomics20,63–65, we comprehensively assessed the ARGs harbored by travelers’ gut microbiota. In contrast to other studies2, we
found that travelers’ resistomes were temporally stable throughout
their stay, with marginal increases noted in ARG abundance over time.
This difference can be partially attributed to different travel destinations, as the country and region visited can have profound effects on
ARG acquisition3,66,67. Nonetheless, we found that diarrheal events
signiﬁcantly altered travelers’ microbiomes and resistomes, resulting
in the enrichment of ARGs—particularly those encoded by Enterobacteriaceae species. This observation was corroborated by quantitative analysis of DEC (a key member of the Enterobacteriaceae family)
isolates, where we found isolates from TD subjects encoded more
resistance genes than those from HT subjects even during

asymptomatic periods. We further identiﬁed ARGs strongly associated
with TD subjects and found a small cluster of plasmid-borne,
resistance-conferring genes (blaTEM-148, sul2, aph6, and tetA) likely able
to be mobilized through horizontal gene transfer (HGT). Collectively,
these observations suggest that travelers’ diarrhea is a signiﬁcant risk
factor for increased carriage of MDR E. coli and ARGs in the microbiome. The acquisition of these MDROs can have long-term consequences for the traveler, such as HGT of ARGs to another pathogen
that could potentially cause treatment failures, longer hospitalization
stays, and additional impacts on public health systems as they spread
to new hosts upon return from travel68.
Although we identiﬁed antibiotic use for prophylaxis or treatment
during travel as a signiﬁcant risk factor for increased ARG carriage, we
were unable to separate the effect of speciﬁc antibiotics. Controlled
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Fig. 6 | ARG content of diarrheagenic E. coli isolates. a Boxplot shows higher
number of unique ARGs carried by DEC strains in non-diarrhea samples of TD
subjects compared to HT subjects (n = 189, Wilcoxon test, P < 0.05). The colored
data points represent different DEC strain. P values are multiple-hypothesis test
corrected using Benjamini–Hochberg (FDR) method. Boxes show median and
quartiles; error bars extend to the values within 1.5 interquartile range. Dotplot at
the bottom shows the prevalence of ARGs in DEC isolates obtained from nondiarrheal HT and non-diarrheal TD subjects’ samples. The annotated genes

(blaTEM-148, sul2, aph6, and tetA) were signiﬁcantly associated with TD subjects
after FDR correction (Fisher exact test; P < 0.05). b Co-occurrence network of ARGs
(circles) and mobile elements (triangles). The edges between two nodes represents
the correlation of ARGs and mobile elements in the same contig (within 5 kb). Solid
lines represent signiﬁcant relationships after FDR correction (Student’s t test,
P < 0.05) and shaded regions represent subnetworks. c Examples of arrangements
of ARGs and mobile elements identiﬁed on the same contigs. Underlying data are
provided in the Source Data ﬁle.

intervention studies focused on the impacts of speciﬁc treatment
regimens and/or prophylaxes (e.g., prebiotics, probiotics, synbiotics)
on the gut microbiome and resistome could further inform best
practices to mitigate the collateral damage from antibiotic use69–72.
While it is unlikely that all taxa and ARGs that correlate with travel and
diarrhea outcomes in our study would translate to other countries,
which could have different infectious diseases burdens and ARG
abundances, we predict that our ﬁndings regarding microbiome and
resistome dynamics and acquisition of MDROs may be broadly generalized. Further multi-cohort travelers’ studies to countries with different pathogen etiologies are warranted to best inform treatment and
mitigation strategies that minimize microbial disruption and MDRO
acquisition during travel.

Methods
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Study design and cohort overview
Our cohort of international travelers was comprised of Spanish language students who were enrolled at the Amauta Spanish School in
Cusco, Peru. A clinic staffed by a study physician was established
inside the school to enroll and follow subjects. Travelers aged ≥18
years, able to understand written English, and enrolled at the school as
students were eligible. The majority of these travelers stayed in lodging provided by the school within its premises. The study physician
explained the purpose and procedures of the study to potential participants within 24 to 48 h of their arrival in Cusco city. Those who
agreed to participate signed an informed consent form and completed
a standardized enrollment questionnaire, that collected baseline
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demographic and epidemiologic data, as well as medical and travel
history (Form A in Supplemental Information). Subjects were also
provided a stool collection kit and instructions to collect a baseline
stool sample with their next bowel movement. Weekly stool samples
were collected from subjects throughout their stay, and a weekly
questionnaire collected data on unreported diarrheal episodes and
dietary habits. Subjects were instructed to immediately communicate
with the study physician when having a diarrheal episode and before
taking any medication (e.g., antibiotics). Diarrhea was deﬁned as passing one or more semi-liquid or watery bowel movements associated
with gastrointestinal symptoms such as abdominal pain, cramping
and/or nausea. Subjects reporting diarrhea were asked to provide an
extra stool sample and were examined daily. During the diarrheal illness, 70 participants were prescribed antibiotics (e.g., ciproﬂoxacin,
azithromycin) supplemented with oral rehydration therapy, and the
remaining individuals were advised only oral rehydration therapy. Few
individuals (n = 8) took antispasmodic and antiparasitic medication.
Physical exam ﬁndings, symptoms, duration, and medications were
documented in an acute diarrhea questionnaire (Form B in Supplemental Information). Diarrheal episodes were treated as independent
events if an asymptomatic period of at least seven days occurred
between them. Samples were classiﬁed as non-diarrhea or diarrhea
based on whether they were collected during a diarrheal episode or
not. Samples were also given a stool grade based on the Bristol stool
form scale (BSS) of stool consistency, ranging from grade 1 (normal,
hard) to grade 4 (loose, diarrheal).
The study protocol and its amendments were reviewed and
approved by the Institutional Ethics Committee of the Universidad
Peruana Cayateno Heredia, the Institutional Review Board of the US
Naval Medical Research Unit No. 6 (NAMRU-6), and the Washington
University in St. Louis Institutional Review Board.

Empirical selection of diarrheal samples for analysis
Since diarrhea is a complex clinical infection and reliance on selfreported information alone can be misleading, we implemented a
multi-factor selection procedure using epidemiological and clinical
information to screen diarrheal samples prior to downstream analyses. First, we veriﬁed that the diarrheal samples were collected
within the documented onset and recovery dates. If the recovery
date was missing from the metadata, only diarrheal samples collected within two days of onset were included; if both onset and
recovery dates were missing, then only samples that had a stool
consistency of 3 or 4 (semi-liquid to liquid) were included. We then
implemented a modiﬁed scoring scheme73,74 referred here as the TD
score, to further minimize the false positives (Supplementary
Table 14). The TD score combined the presence of clinical signs
(such as fever, vomiting, dehydration e.t.c.) and macroscopic data
(stool consistency) collected during the diarrheal episode into a
single metric. These parameters included: (1) stool frequency (in the
last 24 h) and consistency; (2) duration of diarrhea; (3) participantreported dehydration; (4) behavioral signs (e.g., nausea, fatigue,
headache, bloating, anorexia) and/or clinical symptoms (e.g., temperature >38 °C); (5) pulse rate >100; and (6) presence of blood in
stool. Each parameter was further divided into thirds and assigned
equal points based on the severity of the symptom (1 point: bottomthird, 2 points: middle-third, and 3 points: upper-third) and were
aggregated across parameters. We analyzed the TD score validity by
comparing it with individual factors such as stool grade, maximum
stool frequency in 24 h, and duration of diarrhea. While the individual factors did not necessarily correlate with each other, the TD
score was signiﬁcantly correlated with the given factors (Supplementary Discussion). Diarrheal samples with a TD score greater than
1.5 were included in the analysis. Using this multi-faceted ﬁltering
strategy, we selected 102 diarrheal samples total for downstream
analyses.
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Stool specimen processing
All collected stool samples were delivered to the onsite clinic. Samples
were refrigerated at 4 °C and preserved in Cary Blair media then
transported to the Universidad Peruana Cayetano Heredia laboratory
in Cusco, Peru within 2 h. Stool samples from diarrheal episodes that
started during the night hours were collected by study personnel and
refrigerated at 4 °C until they could be delivered the next morning. In
the laboratory, stool samples were examined macroscopically for
consistency and appearance, microscopically for parasite detection
and fecal leukocytes, and underwent routine stool culture followed by
antimicrobial sensitivity testing. Aliquots of fresh stool with no preservatives were frozen at −80 °C. Primary isolates and fresh stool aliquots were shipped in dry ice on a monthly basis to NAMRU-6 in Lima,
Peru for further workup and long-term storage. Samples stored at
−80 °C were shipped to Washington University in St. Louis, MO where
the samples were stored at −80 °C until DNA extraction.

Stool assessment and cultures for enteropathogen detection
and antibiotic susceptibility testing of isolates
Stool samples were collected and processed immediately upon arrival
at the nearby laboratory in Cusco. Gross examination and Hemoccult
card tests (Beckman Coulter, Brea, CA) were used to evaluate for fecal
gross and occult blood, respectively. Stool microscopy using direct
iodine wet mount, modiﬁed Kinyoun stain, and methylene blue stain
techniques were performed to examine for the presence of parasite
ova, cyst, and fecal leukocytes, respectively as previously described75.
Bacterial cultures were performed for the presence of pathogenic E.
coli, Salmonella spp., Shigella spp., Campylobacter spp., Aeromonas
spp., Plesiomonas spp., and Vibrio spp. All primary, enrichment, and
biochemical differentiation culture media, BBL Sensi-Discs susceptibility discs, and catalase and oxidase test reagents were purchased
from Difco BD Bioscience (Franklin Lakes, NJ). Fresh stool samples and
stools preserved in Cary Blair transport media were cultured for bacterial
enteropathogens
using
conventional
microbiologic
techniques76,77. Enteropathogens were identiﬁed according to their
growth on differential and selective agar plates78. Stool specimens
were streaked onto MacConkey agar, Salmonella-Shigella agar (SS),
Hektoen Enteric agar (HE), thiosulfate citrate bile salt sucrose agar
(TCBS), and Campylobacter blood-free agar base (CBF). All agar culture
plates were incubated at 37 °C for 24 h after inoculation with the
exemption of Campylobacter blood-free agar base plates that were
incubated at 42 °C for 48 h in microaerophilic conditions. Stool samples were also inoculated into selenite enrichment broth and peptone
water as sub-cultures and incubated at 37 °C for 18–20 h after inoculation. After incubation, the selenite enrichment broth was streaked
onto HE agar to assess for Shigella spp. and the peptone water was
streaked in the TCBS agar to screen for Vibrio spp. and both were
incubated at 37 °C for 24 h. Five lactose fermenting colonies with
morphology compatible with E. coli were selected from each MacConkey agar plate and preserved for polymerase chain reaction
detection of pathogenic E. coli as described below. Other colonies with
morphology and characteristics of enteropathogens seen on the
MacConkey, SS, HE, and TCBS agars were inoculated in motility indole
ornithine agar (MIO), Kliger iron agar (KIA), lysine iron agar (LIA), and
Simmons citrate (CIT) and incubated at 37 °C for 24 h. After incubation, enteropathogen differentiation was performed according to their
growth characteristics in the different agars and differential biochemical reactions78. Colonies growing on the CBF agar were evaluated
with oxidase, catalase, and gram stain testing to differentiate Campylobacter colonies. Colonies with morphology and biochemical proﬁle
consistent with Shigella were conﬁrmed by agglutination with
serotype-speciﬁc antisera.
After biochemical identiﬁcation, all the lactose fermenting and
enteropathogens colonies identiﬁed were shipped to NAMRU-6 in
Lima for quality control and further workup. For transportation,
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lactose fermenting colonies were inoculated again in MacConkey agar
and Campylobacter colonies were inoculated in CBF agar, all were
incubated at 37 °C for 24 h, and isolated colonies resuspended in
cryovials with trypticase soy broth with 15% glycerol, frozen at −70 °C,
and shipped overnight on dry ice. The colonies identiﬁed as Salmonella spp., Shigella, Aeromonas spp., Plesiomonas spp., and Vibrio spp.
were inoculated in vials containing trypticase soy agar, incubated at
37 °C for 24 h, and shipped overnight at 4–8 °C.
All identiﬁed enteropathogen colonies were inoculated on
Mueller-Hinton (MH) agar to perform antibiotic susceptibility testing
using the Kirby Bauer disk diffusion method according to the Clinical
and Laboratory Standards Institute (CLSI) guidelines79. Antibiotic susceptibility testing was performed with 17 antibiotic discs (amoxicillinclavulanate, ampicillin, azithromycin, ceftriaxone, chloramphenicol,
cephalothin, cefepime, ciproﬂoxacin, rifaximin, amikacin, gentamicin,
imipenem, tetracycline, trimethoprim-sulfamethoxazole, ticarcillin,
ticarcillin/clavulanate, and furazolidone). Colonies were suspended in
sterile saline and turbidity adjusted to the 0.5 McFarland standard
before plating onto MH agar using the lawn streak technique. Antibiotic discs were added with proper spacing between and plates were
incubated at 37 °C for 18–20 h after inoculation. Zones of inhibition
were measured and recorded as the diameter of growth inhibition,
with interpretation of susceptibility or resistance determined using
CLSI M100 published breakpoints. It is important to note that currently there is no established CLSI breakpoint for determining the
azithromycin resistance in E. coli. However, azithromycin has been
found to be highly effective and is frequently used in treating diarrheal
infections caused by Gram-negative pathogens, including diarrheagenic E. coli. In this study, we deﬁned azithromycin resistance as per80,
where the minimum inhibitory concentration of azithromycin was
determined in accordance with CLSI guidelines using the agar dilution
method on all isolates with halo diameter <15 mm.
PCR detection of pathogenic E. coli. Five lactose-positive colonies
were selected randomly from each participant stool culture plate and
shipped frozen at −70 °C to NAMRU-6 in Lima for quality control and
real-time ﬂorescence-based multiplex PCR for the detection of the
currently recognized classes of diarrheagenic E. coli as previously
described81,82.
Frozen stocks of isolated colonies were restreaked onto MacConkey agar and incubated at 37 °C for 18–20 h. For DNA extraction, a
single lactose-positive colony was carefully removed from the MacConkey agar plate using a sterile toothpick to avoid agar contamination
and placed individually into a vial with 100 μl of sterile molecular-grade
water. DNA was extracted by boiling at 100 °C for 5 min, then 5 min on
ice, followed by centrifugation at 14,000 rpm for 10 min at 4 °C.
Primers were designed as previously described82 to detect eight
different virulence genes simultaneously in a single reaction, including
aggR for enteroaggregative E. coli (EAEC), ST1a/ST1b, and LT for enterotoxigenic E. coli (ETEC), eaeA for enteropathogenic E. coli (EPEC), stx1
and stx2 for Shiga toxin-producing E. coli (STEC), ipaH for enteroinvasive
E. coli (EIEC), and daaD for diffusely adherent E. coli (DAEC)82. The primers were designed so that amplicons had differential melting temperatures (TmS) ranging from 77 to 95 °C. The primers were diluted
with TE buffer pH: 8.0 to obtain a 100 μM stock concentration,
then further diluted to 25 μM working concentration with molecular
grade water.
Two microliters of the DNA extraction lysate was used as a template added with 23 μl PCR master mix for a ﬁnal reaction volume of
25 μl including Phusion High Fidelity buffer (Finnzyme OY, Espoo,
Finland) and 0.5 U Phusion polymerase with 200 μM deoxynucleoside
triphosphates and 4 mM MgCl2 (ThermoScientiﬁc, Waltham, MA). Sybr
green I was added as recommended by the manufacturer (Cambrex
Bio Science, Rockland, ME). The qPCR was performed on Rotor-Gene Q
PCR thermocycler with software version 1.7 (Qiagen, Germantown
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MD). Cycling conditions were 98 °C for 50 s, 60 °C for 20 s, 72 °C for
30 s, and 75 °C for 1 s over a total of 25 cycles, after which melting
curves were determined with a ramp speed of 2.5 °C/s reading each
0.2 °C increments between 73 and 95 °C82. Melting peaks were calculated by the software to allow the interpretation of reactivity for the
different virulence factor genes. Reference strains for each pathogenic
E. coli were included as positive controls in the reaction.
RT-PCR for norovirus detection. Stool specimens were transported in
portable coolers on ice packs to the ﬁeld laboratory, aliquoted, and
were stored at –80 °C until they were shipped in batches on dry ice to
the NAMRU-6 laboratory in Lima for testing. Specimens were treated
as described previously83 with some modiﬁcations. In brief, fecal
samples were diluted 10% in 1× phosphate-buffered saline, vortexed,
and centrifuged at 5943 × g for 10 min at 4 °C84. Total RNA was
extracted from stool-diluted samples using the QIAmp Viral RNA mini
kit (Qiagen, Valencia, California) as described by the manufacturer.
RNA was eluted with 60 µL of 0.01% of RNAse inhibitor (Qiagen) in
DEPC Treated Water (Invitrogen, Life Technologies, Waltham, MA).
RNA samples were stored at −80 °C until use. Norovirus detection was
performed using a Duplex genogroup-speciﬁc real-time reversetranscription polymerase chain reaction (qRT-PCR) developed and
described by the National Calicivirus Laboratory at the Centers for
Disease Control and Prevention in a 7500 FAST real-time platform
(Applied Biosystems, Waltham, MA)85,86. RT-PCR was performed at
45 °C for 10 min and 95 °C for 10 min followed by 45 cycles of 15 seconds at 95 °C and 1 min at 60 °C using primers and probes from previous assays87,88. A sample was considered positive for norovirus GI
when the calculated cycle threshold (Ct) was less than or equal to 37
cycles and considered positive for GII when the Ct was less than or
equal to 39 cycles. Test results were only considered valid when all
quality control positive reactions were below Ct cutoff and did not
exhibit ﬂuorescence above the threshold for the negative template
control reactions.

Metagenomic DNA extraction and sequencing
Metagenomic DNA (mgDNA) was extracted from 300–400 mg stool
samples using the phenol-chloroform repeated bead-beating protocol
as described previously21. The extracted mgDNA was diluted to 0.5 ng/
μL and sequencing libraries were prepared using a modiﬁed Nextera
protocol89. The libraries were puriﬁed using the Agencourt AMPure XP
system (Beckman Coulter) and quantiﬁed using the Quant-iT PicoGreen dsDNA assay (Invitrogen). For each sequencing lane, 10 nM of
approximately 96 samples were pooled three independent times.
These pools were quantiﬁed using the Qubit® dsDNA BR Assay and
combined in an equimolar fashion. Samples were submitted for
2x150bp paired-end sequencing on an Illumina NextSeq-High Output
platform at The Edison Family Center for Genome Sciences & Systems
Biology at Washington University in St. Louis.

Metagenome proﬁling
Metagenomics raw reads were processed to remove Illumina adapter/
index sequences and low-quality reads using Trimmomatic (v0.36)90
with the following parameters ILLUMINACLIP:NexteraPE-PE.fa:2:30:
10:1:true; SLIDINGWINDOW:4:15; LEADING:10 TRAILING:10; MINLEN:
60. The removal of human reads contaminants was performed using
deconseq (v0.4.3)91. Post-cleaning, 710 samples with >3 million reads
were used in downstream analyses. The taxonomic composition was
determined using Metaphlan217. Taxa with <0.01% relative abundance
in >90% of samples were removed, resulting in 143 species included in
downstream comparative analyses.

Functional metagenomics
We constructed 21 small-insert (2–5 kb) functional metagenomic
libraries, which were screened against 17 antibiotics (Supplementary
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Data 1) based on our previously published protocols19–23. The experimental protocol is described below:

Library preparation
The mgDNA extracted from 10 randomly selected stool samples were
pooled together for the construction of each individual functional
metagenomic library. The pooled mgDNA was sheared with Covaris
E220 sonicator following the manufacturer’s recommended settings
for a target size of 3 kb (DNA mass: 2–20 µg of mgDNA diluted in 200ul
of Buffer EB, intensity: 0.1, duty cycle: 20%, cycles per burst: 1000,
treatment time: 600 sec). The sheared mgDNA was size-selected by gelelectrophoresis (1% agarose, 0.5× Tris-borate-EDTA, GelGreen dye
(Biotium), 70 V for 130 min). The band covering 2–5 kb fragment size
was excised, then mgDNA fragments were recovered using the QIAquick gel extraction kit (Qiagen). The size-selected mgDNA fragments
were end-repaired with the END-ItTM DNA End Repair kit (Epicenter)
and puriﬁed with the QIAquick PCR puriﬁcation kit (Qiagen). The endrepaired mgDNA was quantiﬁed with the Qubit HS ﬂuorometer assay
kit (Invitrogen) and concentrated using a vacuum concentrator
(SpeedVac®) to a ﬁnal volume of ~10 µl. The mgDNA fragments were
then ligated into the pZE21-MCS-1 vector at the BamHI site. Linearization of the pZE21 vector was performed by inverse PCR using the following reaction conditions: (1) Mix 10 µl of 10× reaction buffer, 1.5 µl of
10 mM dNTP mix, 1 µl of MgSO4, 1 µl of 100 pg/µl circular pZE21 plasmid
vector, 0.75 µl forward primers (5’ GACGGTATCGATAAGCTTGAT 3’),
0.75 µl reverse primers (5’ GACCTCGAGGGGGGG 3’), 0.4 µl blunt-end
HF DNA polymerase and 29.6 µl of nuclease-free water to a ﬁnal volume
of 50 µl. (2) PCR settings: 95 °C for 5 min, then 35 cycles of [95 °C for
45 sec, 55 °C for 45 sec, 72 °C for 2.5 min], then 72 °C for 5 min. The
linearized pZE21 plasmid vector was size-selected (~2200 bp) using gelelectrophoresis, puriﬁed with the QIAquick PCR puriﬁcation kit (Qiagen), and then dephosphorylated with calf-intestinal alkaline phosphatase (CIP, New England BioLabs) by adding 40 µl of gel-puriﬁed
DNA, 5 µl of CIP (10 U/µl), and 5 µl of the 10× reaction buffer. The 50 µl
reaction was incubated overnight at 37 °C before the CIP was heatinactivated by incubating the reaction mix at 70 °C for 15 min. The
ligated plasmid DNA was then puriﬁed using the QIAquick PCR puriﬁcation kit (Qiagen) dialyzed with cellulose membrane (Millipore,
VSWP09025) for 30 min, and then electroporated into E. coli MegaX
DH10B (Invitrogen) following the manufacturer’s instructions. After
transformation, cells were recovered in 1 ml of recovery medium
(Invitrogen) for 1 h at 37 °C. The library titers were determined by
plating 0.1 µl and 0.01 µl of recovered cells onto Luria-Broth (LB) agar
plates containing 50 µg/ml kanamycin as previously described20. The
remainder of recovered cells were grown overnight in 50 ml of LB
broth containing 50 µg/ml kanamycin (LB-Kan). The culture was then
centrifuged and resuspended in 15 ml of LB-Kan broth containing 15%
glycerol and stored at −80 °C for subsequent screening. Functional
screening of antibiotic resistance: Each metagenomic expression library
was screened on Mueller-Hinton agar with 50 µg/ml kanamycin and one
of the 17 antibiotics at concentration listed in Supplementary Data 1.
Before plating each library on antibiotic-containing growth media, the
concentration of each library was adjusted such that 100 µl of library
freezer stock contained at least 10× the total number of unique clones
as determined at the time of library creation. To adjust the concentration, the freezer stock solution was either diluted with MH-Kan
or centrifuged and reconstituted again in the appropriate volume for
plating. The antibiotic selection plates were incubated for 24 h at 37 °C
to allow growth of antibiotic-resistant clones. Additionally, for each
antibiotic selection, a negative control plate of E. coli MegaX DH10B
strain transformed with unmodiﬁed pZE21 (i.e., without a metagenomic
insert) was plated to ensure that the concentration of antibiotic used
entirely inhibited the growth of clones containing unmodiﬁed pZE21.
The surviving colonies from each antibiotic selection were collected by
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adding 750 µl of LB-Kan with 15% glycerol, and colonies were scraped
with an L-shaped spreader. The slurry of antibiotic-resistant clones
removed from the surface of the plate was stored at −80 °C before
sequencing them with Illumina NextSeq platform.

Sequencing, assembly, and annotation of functionally-selected
resistance determinants
The plasmid DNA containing antibiotic-resistant mgDNA fragments was
extracted from functionally-selected clones using the QIAprep Spin
Miniprep kit (Qiagen), and prepared for sequencing with a Nextera
protocol, as described above. The samples were submitted for
sequencing using an Illumina NextSeq platform (2 × 151 bp paired-end
reads). Reads from each antibiotic selection were assembled into contigs using PARFuMS19, a tool speciﬁcally designed for high-throughput
assembly of resistance-conferring DNA fragments from functional
selections. Selections were excluded from analysis if: (1) the number of
contigs assembled was 10 times more than the total number of colonies;
or (2) >200 contigs were assembled. Contigs were also ﬁltered based on
length (>500 bp). A total of 7020 contigs were obtained, and 16,334
open reading frames (ORF) were predicted in these contigs using the
gene-ﬁnding algorithm Prodigal90. These ORFs were then annotated
using an in-house pipeline called resAnnotator.py, which follows a
hierarchical approach: (1) ORFs are searched against BLAST-based ARG
databases (CARD46, ResFinder46, and AMRFinder-Prot47) with high
percent-identity (>95%) and coverage (>95%); and (2) the remaining
ORFs are annotated using HMM-based ARG databases (Resfams91,
AMRFinder-fam47). Overall, 1233 unique ARGs were identiﬁed.

Resistome proﬁling of metagenomics samples
The relative abundance of ARGs in the metagenomics samples was
calculated using ShortBRED18(v0.9.4). First, we built a high-precision
ARG-speciﬁc markers database from 7,921 antibiotic resistance proteins that were used as proteins of interest for identiﬁcation of marker
families using ‘shortbred_identify.py’ with the following non-default
parameters: --clustid 0.95 --ref Uniref9092. The antibiotic resistance
protein sequences include sequences from the CARD database46, the
NCBI-AMR database47, and antibiotic resistance proteins identiﬁed
using functional metagenomics in this cohort, and previous
studies19,21–23,93–97. In total, we generated a comprehensive set of markers database consisting of 6,585 unique marker sequences representing 2,331 AMR gene families. These AMR gene families were then
manually curated, and entries with the following criteria were removed
from analysis consideration because they would not be conﬁdently
expected to provide resistance based solely on a short-read marker
(e.g., when that gene would require other components to provide
phenotypic resistance, or when short-read markers would not distinguish between susceptible vs. resistant versions of an antibiotic target):
(1) Genes associated with global gene regulators, two-component
system proteins, and signaling mediators (e.g., blaZ, vanS-vanR,
mecI, mepR, gadW, marR);
(2) Genes encoding subunits that are part of multiple efﬂux pumps
(e.g., tolC, oprM, opmD);
(3) Resistance via mutation in genes (e.g., resistance to antifolate drugs
via mutations in dhfr, resistance to rifamycin via mutation in rpoB);
(4) Genes conferring resistance by modifying cell wall charge
(e.g., mprF);
(5) Genes that reduce permeability (e.g., omp38, tmrB) or confer
resistance through overexpression (e.g., Thymidylate synthase);
and
(6) General efﬂux pumps that came through functional selections
(e.g., MFS-type, ABC-type)
The relative abundance of AMR gene families was quantiﬁed
by mapping reads to the ﬁltered set of marker sequences using
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‘shortbred_quantify.py’. ShortBRED hits were ﬁltered-out if they had
counts lower than 2, or a mean reads per kilobase million (RPKM) lower
than 0.001.

Bacterial DNA isolation, sequencing, and assembly
The E. coli isolates stored at −80 °C in 15% glycerol were inoculated in
1.5 ml tryptic soy broth and were grown overnight at 37 °C with shaking. Genomic DNA was extracted using the Biostic Bactermia DNA
isolation kit as per the manufacturer’s protocol. DNA concentration
was quantiﬁed using the Qubit ﬂuorometer and stored at −20 °C. Isolate sequencing libraries were prepared using the Nextera protocol89,
and were sequenced on the Illumina NextSeq platform with 2 × 150
paired-end reads. Raw sequencing reads were binned by index
sequences, quality ﬁltered using Trimmomatic(v0.36)98 and human
contaminants were removed by DeconSeq (v0.4.3)99. Processed reads
were assembled into draft genomes using SPAdes (v3.11.0)100 with the
following parameters: spades.py -k 21,33,55,77 --careful. Assembly
quality was assessed using CheckM101 and the following inclusion criteria were used for downstream analysis: >90% completeness, <5%
contamination, and <500 contigs longer than 500 bp.

Genomic analysis of E. coli isolates
The assemblies of 189 E.coli isolates and 40 publicly available E.coli
reference genomes were annotated using Prokka (v1.12)102 with default
parameters. Multilocus sequence types and serotype were determined
using MLST (https://github.com/tseemann/mlst) and SerotypeFinder103.
In silico detection of antibiotic resistance and virulence genes in
the isolate genomes was performed using the in-house pipeline
resAnnotator.py, which sequentially annotates ORFs by searching
against the given Blast- and HMM-based databases. For antibiotic
resistance genes, we screened against the following databases in order:
Resﬁnder104, NCBI-AMR47, CARD46, and Resfams91. For virulence gene
identiﬁcation, VirulenceFinder105,106 and VFDB107 were used. Mobile
genetic elements in the isolate genomes were predicted by
MGEFinder54. Average nucleotide identities among isolates were
computed using pyani (https://github.com/widdowquinn/pyani). The
pangenome analysis was performed using Roary49, with core-genome
alignments created from assembled contigs of all E. coli isolates
(189 sequenced and 40 published reference genomes). The reference
genome of E. marmotae was also included as an outgroup. The
maximum-likelihood core-genome phylogenetic tree was constructed
using RAXML (v8.2.11)50 with the following parameters: -m GTRGAMMA
-f a -N 1000 -x 25418 and visualized using iTOL108.

Statistical analysis
Identiﬁcation of covariates. To identify the metadata variables that
signiﬁcantly affected the taxonomic proﬁle, functional proﬁle, and
resistome proﬁle, we calculated the total variance contribution of each
variable using PERMANOVA with repeated measures, as described
previously25. To account for repeated measurement in metadata variables that change over time (e.g., stool consistency, sample type,
pathogen presence), permutations were limited to within the subjects.
Meanwhile, variables that were constant across samples from the same
subject (e.g., age, sex, travel history, lodging, country of origin) were
ﬁrst permuted across subjects, with samples re-labeled with the variable from their permuted subject. The signiﬁcance value for metadata
variables was determined using 5,000 permutations and p values that
were FDR corrected for multiple-hypothesis testing. The metadata
variables that showed signiﬁcant variation among these proﬁles were
included in the models as covariates.
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effect model (GLMM) with Poisson family (for modeling count data e.g.
richness) was ﬁt by maximum-likelihood using lmer or glmer function
in R, respectively. These models include regression on alpha diversity,
beta-diversity, and cumulative change in abundance measures against
diarrhea and time while also adjusting for the effects of age, sex,
region, and inter-individual variability by specifying subjects as the
random effects. Pseudo-R2 was determined using r.squaredGLMM
function in the MuMin package. Post hoc pairwise comparison
between different Sample Type (e.g., DiarrheaTD vs Non-diarrhea
PostTD) was performed on ﬁtted models using emmeans package and
P values were corrected for multiple hypotheses using
Benjamini–Hochberg method (FDR).
Microbial features association analysis. To identify microbial features (taxa or ARGs) associated with diarrhea, we performed multivariable association analysis using MaAsLin227 that accounts for
multiple covariates and repeated measures. Brieﬂy, Masslin2, ﬁrst
applies an appropriate transformation/normalization method: arcsine
square-root transformation for taxonomic proﬁle and log transformation with half the minimum relative abundance as a pseudo count.
Then, the transformed abundances of each feature were ﬁt with the
following linear mixed-effects model:
microbial f eature abundances ðtaxa or AR genesÞ ∼ Sample type
+ Age + Sex + Region + AbxUse + Time in PeruðdaysÞ + 1∣SubjectsÞ
where each microbial feature was modeled as a function of diarrhea
while adjusting for the effect of metadata variables (signiﬁcant covariates that came from PERMANOVA analysis) as well as accounting for
inter-individual variability by specifying the subjects as random
effects. Further, p values of each feature were corrected for multiplehypothesis testing using Benjamini–Hochberg method with
FDR < 0.25.

Microbiome network analysis
We inferred two unsupervised co-occurrence networks from diarrhea
(case) and non-diarrhea (control) samples at the species-level using the
SparCC44 algorithm which calculates the correlations between the
microbial species while taking into account the sparsity and inherent
compositionality in the microbe relative abundance data. To account
for differences between the number of diarrheal and non-diarrheal
samples, we took subset of samples to construct co-occurrence networks. For the diarrhea network, only the ﬁrst diarrhea samples per
individual were considered, whereas non-diarrheal samples that were
collected within the ﬁrst two weeks of stay and were not ﬂanked by a
diarrheal episode were included in the non-diarrhea network. For the
given diarrhea and non-diarrhea datasets, SparCC was used with
default parameters to calculate the correlations among species, and
then the “MakeBootStrap” command was applied to generate 100
bootstrap tables, which were again used to calculate the SparCC correlations. Finally, the bootstrapped correlations were used with the
“PseudoPvals.py” command to generate two-tailed p values from the
true table. The correlation values with p values <0.05 were retained.
We then compared the two co-occurrence networks using NetShift45
which quantiﬁes the changes in the interactions of the individual node
to identify the “driver taxa”. The key parameters for identifying the
driver taxa were the NESH score, Jacard index and delta betweenness
centrality. The co-occurrence networks were drawn using the igraph
package in R.

Microbiome shift events
Longitudinal changes in alpha- and beta-diversity. To model the
effect of length of travel and diarrhea on gut microbial and AR gene
diversity, a linear mixed effect model (LMM) (for modeling continuous
response variables, e.g., Shannon index) or generalized linear mixed
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Microbiome “shift”25 events were deﬁned as when the Bray–Curtis
dissimilarity index between two consecutive samples from a single
individual was more likely to have come from the distribution of the
Bray–Curtis dissimilarity index derived from samples of different
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individuals. Based on this deﬁnition, we ﬁrst obtained the distribution of the Bray–Curtis dissimilarity index between samples
from different individuals of the HT cohort and the Bray–Curtis
dissimilarity index between samples from the same individuals of
the HT cohort. The point at which the inter-individual dissimilarity
estimate exceeded the intra-individual dissimilarity estimate was
chosen as the threshold to deﬁne the “microbiome shift” event
(Bray–Curtis dissimilarity: 0.52).

Machine learning classiﬁcation model
To distinguish diarrheal from non-diarrhea samples based on taxonomic composition, we built machine learning classiﬁcation models
using SIAMCAT43, an ML-based tool box developed speciﬁcally for
metagenomics studies109. The SIAMCAT43 workﬂow consists of normalization of taxonomic features, splitting the datasets using crossvalidation schemes (ﬁvefolds), training with different machine learning
models (LASSO logistic regression, Random Forest, and Elastic Net),
and evaluating the performance of the models using area under the
receiver operating characteristic curve.
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Reporting summary
Further information on research design is available in the Nature
Portfolio Reporting Summary linked to this article.
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Data availability
All data from shotgun metagenomics, isolates, and functional metagenomics sequencing are available from the NCBI SRA under BioProject ID PRJNA698223. The source data underlying main text ﬁgures and
supplementary ﬁgures are provided as a Source Data ﬁle. Source data
are provided with this paper.
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Code availability
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reasonable request.
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